These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35265550)

  • 1. Pityriasis Rosea Induced by COVID-19 Vaccination.
    Khattab E; Christaki E; Pitsios C
    Eur J Case Rep Intern Med; 2022; 9(2):003164. PubMed ID: 35265550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pityriasis rosea and pityriasis rosea-like eruption after anti-SARS-CoV-2 vaccination: a report of five cases and review of the literature.
    Veraldi S; Boneschi V; Cusini M; Maronese CA
    Dermatol Reports; 2023 Mar; 15(1):9503. PubMed ID: 37063394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature.
    Buckley JE; Landis LN; Rapini RP
    JAAD Int; 2022 Jun; 7():164-168. PubMed ID: 35156062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manifestation of pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccine: A systematic review.
    Khan I; Elsanousi AA; Shareef AM; Tebha SS; Arif A; Gul S
    Immun Inflamm Dis; 2023 Apr; 11(4):e804. PubMed ID: 37102660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine.
    Valk B; Bender B
    Cutis; 2021 Dec; 108(6):317-318. PubMed ID: 35167784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pityriasis Rosea Eruption Following the Administration of Oxford-AstraZeneca Vaccine.
    Marghalani S; Alghamdi Y; Albrakati BA; Huwait HF; Mohanna AT
    Cureus; 2024 Mar; 16(3):e56310. PubMed ID: 38628985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pityriasis Rosea after COVID-19 Infection.
    Prtajin M; Ljubojević Hadžavdić S
    Acta Dermatovenerol Croat; 2022 Dec; 30(4):265-266. PubMed ID: 36919396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination.
    Shin SH; Hong JK; Hong SA; Li K; Yoo KH
    Int J Infect Dis; 2022 Jan; 114():88-89. PubMed ID: 34740803
    [No Abstract]   [Full Text] [Related]  

  • 9. Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine.
    Cyrenne BM; Al-Mohammedi F; DeKoven JG; Alhusayen R
    J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):e546-e548. PubMed ID: 33982814
    [No Abstract]   [Full Text] [Related]  

  • 10. Six cases of pityriasis rosea following SARS-CoV-2 vaccination with BNT162b2.
    Ramot Y; Nanova K; Faitatziadou SM; Assab DA; Berkun Y; Zlotogorski A
    J Dtsch Dermatol Ges; 2022 Aug; 20(8):1123-1124. PubMed ID: 35698860
    [No Abstract]   [Full Text] [Related]  

  • 11. Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination.
    Drago F; Broccolo F; Ciccarese G
    Clin Dermatol; 2022; 40(5):586-590. PubMed ID: 35093476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pityriasis rosea after mRNA COVID-19 vaccination.
    Abdullah L; Hasbani D; Kurban M; Abbas O
    Int J Dermatol; 2021 Sep; 60(9):1150-1151. PubMed ID: 34110010
    [No Abstract]   [Full Text] [Related]  

  • 13. A Review of Pityriasis Rosea in Relation to SARS-CoV-2/COVID-19 Infection and Vaccination.
    Wong N; Cascardo CA; Mansour M; Qian V; Potts GA
    Cureus; 2023 May; 15(5):e38772. PubMed ID: 37303403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pityriasis rosea following SARS-CoV-2 vaccination: A case series.
    Temiz SA; Abdelmaksoud A; Dursun R; Durmaz K; Sadoughifar R; Hasan A
    J Cosmet Dermatol; 2021 Oct; 20(10):3080-3084. PubMed ID: 34363731
    [No Abstract]   [Full Text] [Related]  

  • 15. Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine.
    Cohen OG; Clark AK; Milbar H; Tarlow M
    Hum Vaccin Immunother; 2021 Nov; 17(11):4097-4098. PubMed ID: 34435935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: Case report and brief literature review.
    Pedrazini MC; da Silva MH
    Dermatol Ther; 2021 Nov; 34(6):e15129. PubMed ID: 34533265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pityriasis Rosea and Pityriasis Rosea-like Eruption Following COVID-19 Vaccinations: Case Series from Oman.
    Al Hatmi I; Al Maqbali H; Al Waily A; Al Khalili A; Qureshi A
    Oman Med J; 2023 Nov; 38(6):e579. PubMed ID: 38264510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review.
    Wang CS; Chen HH; Liu SH
    J Formos Med Assoc; 2022 May; 121(5):1003-1007. PubMed ID: 35012825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maculopapular eruptions following COVID-19 vaccination: Pityriasis rosea or pityriasis rosea-like eruptions?
    Ciccarese G; Mastrolonardo M; Serviddio G; Drago F
    J Cosmet Dermatol; 2023 Sep; 22(9):2380-2381. PubMed ID: 37382032
    [No Abstract]   [Full Text] [Related]  

  • 20. Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination.
    Leerunyakul K; Pakornphadungsit K; Suchonwanit P
    Front Med (Lausanne); 2021; 8():752443. PubMed ID: 34557507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.